Does low free T3 with normal free T4 and normal reverse T3 suggest a peripheral conversion bottleneck?

In clinical thyroid evaluation, an isolated biochemical pattern of low free T3 (FT3) with normal free T4 (FT4) and normal reverse T3 (rT3) presents a distinct diagnostic profile that differs from typical systemic illness responses.

Mechanistic pathways of the conversion bottleneck

• Deiodinase Dysregulation: In classic non-thyroidal illness syndrome (NTIS), downregulated type 1 deiodinase (D1) and upregulated type 3 deiodinase (D3) actively shunt T4 into rT3, causing characteristically elevated circulating rT3.
• Atypical Bottlenecks: When rT3 remains within the normal reference range despite low FT3, the etiology shifts from systemic NTIS to a localized peripheral conversion bottleneck. This pattern is associated with tissue-specific type 2 deiodinase (D2) inefficiency or primary genetic variations in the deiodinase-encoding genes (DIO1, DIO2, or DIO3).

Clinical differentiation from non-thyroidal illness

• Exclusion of Classic NTIS: Because rT3 acts as a systemic marker of D1/D3 alteration, a truly normal rT3 level excludes the profound D1-suppressed, D3-activated states characteristic of severe, acute euthyroid sick syndrome.
• Therapeutic Implications: Patients with this primary or tissue-specific deiodinase bottleneck maintain normal TSH feedback but exhibit low active T3. Crucially, their circulating T3 levels often fail to normalize even with standard T4 supplementation, as the underlying peripheral conversion machinery is compromised.

Bottom line

• An isolated biochemical pattern of low FT3, normal FT4, and normal rT3 indicates a localized peripheral T4-to-T3 conversion bottleneck—driven by primary or tissue-specific deiodinase dysfunction—rather than a classic, rT3-dominant non-thyroidal illness syndrome.